Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GrantPax: Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer
NCT02812992Phase 4Completed
- Sponsor
- AIO-Studien
- Start
- Jun 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by AIO-Studien. Started Jun 2016; status: completed.
02
Drugs
paclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02812992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812992.